RETIN-A MICRO Drug Patent Profile

When do Retin-a Micro patents expire, and what generic alternatives are available?

Retin-a Micro is a drug marketed by Bausch and is included in one NDA.

The generic ingredient in RETIN-A MICRO is tretinoin. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the tretinoin profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Retin-a Micro

A generic version of RETIN-A MICRO was approved as tretinoin by PADAGIS US on December 24^th, 1998.

Summary for RETIN-A MICRO

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	140
Drug Prices:	Drug price information for RETIN-A MICRO
What excipients (inactive ingredients) are in RETIN-A MICRO?	RETIN-A MICRO excipients list
DailyMed Link:	RETIN-A MICRO at DailyMed

See drug prices for RETIN-A MICRO

Pharmacology for RETIN-A MICRO

Drug Class

Retinoid

US Patents and Regulatory Information for RETIN-A MICRO

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bausch	RETIN-A MICRO	tretinoin	GEL;TOPICAL	020475-002	May 10, 2002		RX	Yes	Yes
Bausch	RETIN-A MICRO	tretinoin	GEL;TOPICAL	020475-001	Feb 7, 1997		RX	Yes	Yes

Expired US Patents for RETIN-A MICRO

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bausch	RETIN-A MICRO	tretinoin	GEL;TOPICAL	020475-002	May 10, 2002	4,690,825
Bausch	RETIN-A MICRO	tretinoin	GEL;TOPICAL	020475-001	Feb 7, 1997	5,955,109
Bausch	RETIN-A MICRO	tretinoin	GEL;TOPICAL	020475-001	Feb 7, 1997	4,690,825
Bausch	RETIN-A MICRO	tretinoin	GEL;TOPICAL	020475-002	May 10, 2002	5,955,109

International Patents for RETIN-A MICRO

See the table below for patents covering RETIN-A MICRO around the world.

Country	Patent Number	Title	Estimated Expiration
Australia	613398
Australia	603379
Germany	3774266
Germany	3880593
Australia	2164088

Supplementary Protection Certificates for RETIN-A MICRO

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1304992	SPC/GB13/061	United Kingdom		PRODUCT NAME: CLINDAMYCIN PHOSPHATE IN COMBINATION WITH TRETINOIN.; REGISTERED: IE PA1332/043/001 20130322; UK PL15142/0249 20130624
1304992	2013C/060	Belgium		PRODUCT NAME: CLINDAMYCINE (ALS CLINDAMYCINE FOSFAAT) EN TRETINOINE; AUTHORISATION NUMBER AND DATE: BE437507 20130506
1304992	PA2013025	Lithuania		PRODUCT NAME: CLINFAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
1304992	122013000081	Germany		PRODUCT NAME: CLINDAMYCIN (ALS CLINDAMYCIN-PHOSPHAT) UND TRETINOIN; NAT. REGISTRATION NO/DATE: 85210.00.00 20130611; FIRST REGISTRATION: IRLAND PA1332/043/001 20130322
1304992	1390049-3	Sweden		PRODUCT NAME: KLINDAMYCIN (SOM KLINDAMYCINFOSFAT) OCH TRETINOIN; NAT. REG. NO/DATE: MTNR 46193 20130503; FIRST REG.: IR PA1332/043/001 20130322

RETIN-A MICRO Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for RETIN-A MICRO

Introduction to RETIN-A MICRO

RETIN-A MICRO, a topical gel formulation of tretinoin, is a derivative of vitamin A widely used in dermatology for treating various skin conditions, including acne, fine lines, wrinkles, and hyperpigmentation. Here, we delve into the market dynamics and financial trajectory of this product.

Market Size and Growth

The market for tretinoin, the active ingredient in RETIN-A MICRO, is substantial and growing. As of 2024, the global tretinoin market was valued at USD 2.5 billion and is projected to reach USD 7.5 billion by 2031, growing at a compound annual growth rate (CAGR) of 10.1% during the forecast period[3].

Key Drivers of Market Growth

Several factors are driving the growth of the tretinoin market, which directly impacts the demand for RETIN-A MICRO:

Expansion of the Beauty and Cosmetics Sector

The increasing focus on skincare products, particularly those with anti-aging properties, is a significant driver. Tretinoin's skin-renewing and anti-aging benefits make it a popular ingredient in skincare formulations[3].

Prescription Demand

Tretinoin is a prescription-only drug for specific dermatological conditions, and the demand for effective and scientifically validated therapies drives its prescription market. Dermatologists frequently recommend tretinoin for various skin issues, raising consumer awareness and demand[3].

Clinical Development and Research

Ongoing research and development in dermatology and skincare are driving innovation in tretinoin formulations. New products and formulations help expand the market[3].

Patient Preference for Topical Treatments

Patients often prefer topical treatments for dermatological problems, fueling the demand for tretinoin products like RETIN-A MICRO, which are available in various topical formulations[3].

Geographical Market Dynamics

North America

The North American market, including the United States and Canada, is a significant segment for RETIN-A MICRO. The U.S. market, in particular, benefits from a strong retail infrastructure and widespread availability of retinol and tretinoin products across online platforms and brick-and-mortar stores[4].

Europe

Europe also represents a substantial market, with growth supported by innovative product formulations catering to specific skin concerns. The European market's emphasis on personalized skincare solutions further supports the growth of retinol and tretinoin products[4].

Asia-Pacific and Emerging Economies

The Asia-Pacific region, especially countries like China, India, and Indonesia, is experiencing rapid growth due to increasing consumer awareness and rising disposable incomes. This trend is boosting the demand for skincare products, including those containing tretinoin[1][4].

Distribution Channels

RETIN-A MICRO is available through various distribution channels:

Pharmacies and Drugstores

Over-the-counter tretinoin products, including weaker formulations of RETIN-A MICRO, are often available in pharmacies and drugstores[3].

Prescription Dispensing

Stronger formulations of tretinoin, particularly those for specific dermatological conditions, are dispensed through prescription by healthcare professionals[3].

Online Retail

The growing trend of online retail includes the availability of tretinoin-containing products through e-commerce platforms, making it easier for consumers to access these products[3].

Financial Performance and Projections

While specific financial data for RETIN-A MICRO is not provided, the overall market for tretinoin and retinol products offers insights into the financial trajectory:

• The global retinol market, which includes products similar to RETIN-A MICRO, was valued at USD 1.33 billion in 2022 and is expected to grow at a CAGR of 3.8% from 2023 to 2030[1].
• The global retinol beauty products market, specifically, was valued at USD 898.4 million in 2023 and is expected to grow at a CAGR of 5.9% from 2024 to 2030[4].

Competitive Landscape

The market for tretinoin and retinol products is competitive, with several key players:

• BASF SE
• Divi’s Laboratories Limited
• Beauty Solutions Ltd.
• Biotics Research Corporation
• Eluminex Biosciences[1]

These companies are involved in various aspects of the market, from manufacturing to distribution, and play a significant role in driving market growth through innovation and marketing efforts.

Consumer Trends and Preferences

Consumer trends are shifting toward more effective and scientifically proven skincare products. The demand for retinol creams, serums, and oils is robust, driven by consumer awareness of retinol’s efficacy in addressing signs of aging and other skin concerns[4].

Men’s Skincare Segment

The men’s segment is also growing, with an anticipated CAGR of 7.0% from 2024 to 2030. Men are becoming more educated about the benefits of retinol, leading to a higher propensity to invest in skincare products[4].

Key Takeaways

• The global tretinoin market is growing significantly, driven by the expansion of the beauty and cosmetics sector and the demand for effective skincare treatments.
• RETIN-A MICRO benefits from its availability in various distribution channels, including pharmacies, prescription dispensing, and online retail.
• Geographical markets, especially North America and Europe, are crucial for the product’s growth.
• Consumer trends favor scientifically proven ingredients like tretinoin, driving the demand for products like RETIN-A MICRO.

FAQs

What is RETIN-A MICRO used for?

RETIN-A MICRO is a topical gel formulation of tretinoin used to treat various skin conditions, including acne, fine lines, wrinkles, and hyperpigmentation.

How fast is the tretinoin market growing?

The global tretinoin market is projected to grow at a CAGR of 10.1% from 2024 to 2031[3].

Which regions are driving the growth of the tretinoin market?

North America, Europe, and the Asia-Pacific region, particularly emerging economies like China, India, and Indonesia, are driving the growth of the tretinoin market[1][3][4].

What are the key distribution channels for RETIN-A MICRO?

RETIN-A MICRO is available through pharmacies, prescription dispensing, and online retail[3].

Why is the demand for retinol and tretinoin products increasing?

The demand is increasing due to growing consumer awareness of the efficacy of retinol and tretinoin in addressing skin concerns, particularly signs of aging, and the preference for scientifically proven skincare ingredients[1][3][4].

Cited Sources:

1. Grandview Research - Retinol Market Size, Share & Growth Analysis Report, 2030
2. Health Canada - Details for: RETIN-A MICRO
3. Verified Market Research - Tretinoin Market Size, Share, Scope, Trends And Forecast
4. Grandview Research - Retinol Beauty Products Market Size And Share Report, 2030